191 related articles for article (PubMed ID: 2337672)
1. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Morris SW; Daniel L; Ahmed CM; Elias A; Lebowitz P
Blood; 1990 May; 75(10):2035-41. PubMed ID: 2337672
[TBL] [Abstract][Full Text] [Related]
2. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
3. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
[TBL] [Abstract][Full Text] [Related]
5. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
[TBL] [Abstract][Full Text] [Related]
6. CML patients in blast crisis have breakpoints localized to a specific region of the BCR.
Schaefer-Rego K; Dudek H; Popenoe D; Arlin Z; Mears JG; Bank A; Leibowitz D
Blood; 1987 Aug; 70(2):448-55. PubMed ID: 3038213
[TBL] [Abstract][Full Text] [Related]
7. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator.
Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD
Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475
[TBL] [Abstract][Full Text] [Related]
9. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies.
Saglio G; Guerrasio A; Tassinari A; Ponzetto C; Zaccaria A; Testoni P; Celso B; Rege Cambrin G; Serra A; Pegoraro L
Blood; 1988 Oct; 72(4):1203-8. PubMed ID: 3167203
[TBL] [Abstract][Full Text] [Related]
10. Chromosome abnormalities in CML.
Hagemeijer A
Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
[TBL] [Abstract][Full Text] [Related]
11. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
Mills KI; Stewart J; Burnett AK
Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.
Giere IA; Larripa IB
Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967
[TBL] [Abstract][Full Text] [Related]
13. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the location of the breakpoint within the M-bcr and clinical parameters.
Mills KI
Leuk Lymphoma; 1993; 11 Suppl 1():73-9. PubMed ID: 8251922
[TBL] [Abstract][Full Text] [Related]
15. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
17. BCR breakpoint subregions and blast crisis lineage in CML patients.
Martinelli G; Chiamenti A; Gasparini P; Pignatti PF; Ambrosetti A; Zaccaria A; Buzzi M; Testoni N; Tura S; Guerrasio A
Blood; 1992 Feb; 79(3):838-9. PubMed ID: 1732022
[No Abstract] [Full Text] [Related]
18. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis.
Ohno T; Hada S; Sugiyama T; Mizumoto T; Furukawa H; Nagai K
Am J Hematol; 1998 Apr; 57(4):320-5. PubMed ID: 9544977
[TBL] [Abstract][Full Text] [Related]
20. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
Mills KI; Sproul AM; Leibowitz D; Burnett AK
Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
